EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice

Angela Ishak, Nikolaos Mazonakis, Nikolaos Spernovasilis iD, Karolina Akinosoglou, Constantinos Tsioutis

Journal of Antimicrobial Chemotherapy · 03.01.2025 · 80 (1) · 1-17

DOI: 10.1093/jac/dkae380 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 29.10.2024. Verfasst von Angela Ishak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, 48202 Henry Ford Hospital, Detroit, MI, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Synergism, Microbial Sensitivity Tests. Die Arbeit wurde bisher 166-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibacterial activity can be classified as either bactericidal or bacteriostatic, using methods such as the MBC/MIC ratio and time–kill curves. However, such categorization has proven challenging in clinical practice, as these definitions only apply under specific laboratory conditions, which may differ from clinical settings. Several factors, such as the specific bacteria or infectious medium, can affect the action of antibiotics, with many antibacterials exerting both activities. These definitions have also led to the belief that bactericidal antibacterials are superior to bacteriostatic, especially in more severe cases, such as endocarditis, neutropenia and bacteraemia. Additionally, current dogma dictates against the combination of bactericidal and bacteriostatic antibacterials in clinical practice, due to potential antagonism. This review aimed to assess the differences in antibacterial activity of bactericidal and bacteriostatic antibacterials based on in vitro and in vivo studies and examine their antagonistic or synergistic effects. Our findings show that specific bacteriostatic agents, such as linezolid and tigecycline, are clinically non-inferior to bactericidals in multiple infections, including pneumonia, intra-abdominal infections, and skin and soft tissue infections. Studies also support using several bacteriostatic agents as salvage therapies in severe infections, such as neutropenic fever and endocarditis. Additionally, not all combinations of bacteriostatic and bactericidal agents appear to be antagonistic, with many combinations, such as linezolid and rifampicin, already being used. The findings should be interpreted with caution, as most evidence is from observational studies and there is a need for randomized controlled trials to assess their effectiveness and combinations, especially within the context of rising antimicrobial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsDrug SynergismMicrobial Sensitivity TestsHumansBacterial InfectionsBacteriaClinical Relevance

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, 48202 Henry Ford Hospital, Detroit, MI, USA.
  • Department of Internal Medicine, Thoracic Diseases General Hospital Sotiria, 11527 Athens, Greece.
  • Department of Infectious Diseases, German Oncology Centre, 4108 Limassol, Cyprus.
  • School of Medicine, University of Crete, 71500 Heraklion, Greece.
  • School of Medicine, University of Patras, 26504 Rio, Greece.
  • Department of Internal Medicine and Infectious Diseases, University General Hospital of Patras, 26504 Rio, Greece.

ORCID-Profile: Nikolaos Spernovasilis

Zitieren

APA

Ishak, A., Mazonakis, N., Spernovasilis, N., Akinosoglou, K., & Tsioutis, C. (2025). Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice. Journal of Antimicrobial Chemotherapy, 80(1), 1-17. https://doi.org/10.1093/jac/dkae380

Vancouver

Ishak A, Mazonakis N, Spernovasilis N, Akinosoglou K, Tsioutis C. Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice. Journal of Antimicrobial Chemotherapy. 2025;80(1):1-17. doi:10.1093/jac/dkae380

BibTeX
@article{Ishak2025,
  author = {Ishak, Angela and Mazonakis, Nikolaos and Spernovasilis, Nikolaos and Akinosoglou, Karolina and Tsioutis, Constantinos},
  title = {Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  volume = {80},
  number = {1},
  pages = {1--17},
  doi = {10.1093/jac/dkae380}
}
Kostenlos starten →